GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 22692956
|
NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA and Western Blotting | NA | 0.48 | 0.5461 | 22422628
|
NES | 7756 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0573 | 22692956
|
NES | 7756 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA and Western Blotting | NA | 0.48 | 0.0573 | 22422628
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 22692956
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA and Western Blotting | NA | 0.48 | 0.6448 | 22422628
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | Western Blotting | NA | 0.48 | 0.6448 | 24201869
|
HSPA5 | 5238 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | FACs followed by Western Blotting | NA | 0.4 | 0.0117 | 24201869
|
HSPA5 | 5238 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA followed by Western Blotting and FACs | NA | 0.4 | 0.0117 | 20979610
|
ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 22692956
|
ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA and ALDEFLUOR assay | NA | 0.12 | 0.684 | 20979610
|
ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA and ALDEFLUOR assay | NA | 0.12 | 0.684 | 22422628
|
ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 21169409
|
CD24 | 1645 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | FACs | NA | 0.12 | 0.456 | 24201869
|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | FACs followed by SFA | NA | 0.12 | 1 | 22692956
|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | FACs | NA | 0.12 | 1 | 24201869
|
PROM1 | 9454 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | OECM1 | NA | SFA and FACs | NA | 0.12 | 0.7582 | 20979610
|